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ABSTRACT
a globin expression must be regulated properly to
prevent the occurrence of a-thalassemias, yet many
questions remain unanswered regarding the
mechanism of transcriptional activation. Identifying
factors that regulate chromatin structure of the
endogenous a globin locus in developing
erythroblasts will provide important mechanistic
insight. Here, we demonstrate that the BRG1
catalytic subunit of SWI/SNF-related complexes
co-immunoprecipitates with GATA-1 and EKLF in
murine fetal liver cells in vivo and is recruited to
the far-upstream major-regulatory element (MRE)
and a2 promoter. Furthermore, based on our
analysis of Brg1
null/ENU1 mutant mice, BRG1
regulates DNase I sensitivity, H3ac, and H3K4me2
but not CpG methylation at both sites. Most
importantly, BRG1 is required for chromatin loop
formation between the MRE and a2 promoter and
for maximal RNA Polymerase II occupancy at the
a2 promoter. Consequently, Brg1 mutants express
a globin mRNA at only 5–10% of wild-type levels
and die at mid-gestation. These data identify
BRG1 as a chromatin-modifying factor required for
nucleosome remodeling and transcriptional activa-
tion of the a globin locus. These data also demon-
strate that chromatin looping between the MRE and
a2 promoter is required as part of the transcriptional
activation mechanism.
INTRODUCTION
The a and b globin must be expressed at similar levels in
erythrocytes to produce functional hemoglobin consisting
of a2–b2 tetramers; a failure to do so results in globin
chain imbalances and the occurrence of thalassemias (1).
To facilitate their coordinately regulated transcription,
the a and b globin loci are structurally similar with a
series of evolutionarily conserved regulatory elements
that direct tissue-speciﬁc transcription of far-downstream
globin genes (Figure 1A). Furthermore, the genes are
arranged in the order of their developmental expression
with primitive (embryonic) globin genes followed by
deﬁnitive (fetal/adult) globin genes. To account for their
similarity in genomic structure, the a and b loci arose by
duplication of an ancestoral locus at an early stage of
vertebrate evolution  500 million years ago and have
been constrained by purifying selection (2,3).
The b globin locus has been characterized in con-
siderable detail and serves as a model for studying
transcriptional regulatory mechanisms in general and the
relationship between sequence-speciﬁc transcription
factors and chromatin-modifying factors in particular
(4). For example, the zinc-ﬁnger transcription factors
GATA-1 and EKLF bind to their consensus sequences
[(A/T)GATA(A/G) and CACCC, respectively] in the
locus control region (LCR) as well as the b major and b
minor promoters and recruit several co-regulators
including the CBP/P300 histone acetyltransfereases
(HATs) and the BRG1 catalytic subunit of SWI/SNF-
related complexes (5–7). BRG1 occupancy is presumably
reinforced by a bromodomain that binds acetylated
histones (8), and it confers ATPase activity that alters
the conformation and position of nucleosomes (9–11).
As a result, DNase I hypersensitive sites (HSs) indicative
of open chromatin are created in the LCR and the b major
promoter. BRG1 also mediates chromatin looping such
that GATA-1 and EKLF bound sites in HS2 of the
LCR and b major promoter are brought into close
physical proximity while the intervening  40-kb DNA
segment is looped out (12). This step culminates in
maximal RNA Polymerase II recruitment at the
promoter and transcriptional activation.
The a globin locus also contains GATA-1 and EKLF
binding sites in upstream regulatory elements as well as
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several properties with the b globin LCR including the
presence of acetylated histones and HSs in erythroid
cells but not other cell types (13–17). The most highly
conserved of these regulatory elements, which corresponds
to human HS -40 or mouse HS -26, confers robust,
erythroid-speciﬁc enhancer activity on its own and
is referred to as the major regulatory element (MRE)
(18–22). The MRE is diﬀerent from the LCR, however,
because it is embedded in an intron of the ubiquitously
expressed C16orf35 gene (Figure 1A) (23). Considering
that the MRE does not impose erythroid-speciﬁc tran-
scription on the C16orf35 promoter and also lacks a
CTCF insulator, it is believed that the mechanism of
transcriptional regulation is fundamentally diﬀerent for
the a and b globin loci.
Chromosome conformation capture (3C) experiments
have recently demonstrated that the MRE and a2
promoter are brought into close physical proximity in
erythroid cells and the  40kb of intervening DNA is
looped out in a manner analogous to the LCR and b
major promoter (24–26). This ﬁnding suggests a globin
and C16orf35 are recruited to distinct higher order
chromatin environments and are regulated diﬀerently.
Interestingly, EKLF is dispensable for chromatin
looping at the a globin locus but required at the b
globin locus, which highlights another functional diﬀer-
ence in how these two loci are regulated (24). Most
importantly, unlike the b globin locus, it is not known
which chromatin-modifying factors are recruited to the a
globin locus to mediate histone acetylation, nucleosome
remodeling, and chromatin looping. These factors must
be identiﬁed to elucidate the mechanism of a globin
transcriptional activation.
We previously generated and characterized an ENU-
induced hypomorphic mutation in the mouse brahma-
related gene 1 (Brg1, also known as Smarca4) gene that
results in a single amino-acid substitution (E1083G) in
the ATPase domain (27). The mutant protein is stable
and assembles into SWI/SNF-related complexes, but
Brg1
null/ENU1 mutants have markedly reduced nucleo-
some remodeling, chromatin looping, and transcription
of the b globin locus and die between embryonic day (E)
11.5 and 14.5 due to severe anemia (12,27,28). Based
on additional analysis of these mutants, we demonstrate
here that BRG1 also remodels nucleosomes, mediates
chromatin looping, and activates transcription of the
a globin locus. These ﬁndings indicate that a and b
globin transcription are regulated by a common,
BRG1-dependent mechanism.
MATERIALS AND METHODS
RT–PCR
RNA was prepared using Trizol reagent (Invitrogen) and
reverse transcribed using random hexamers and
SuperScript II RT (Invitrogen) according to standard
procedures. For end-stage PCR, the Actin primers were
50-CAAGGTGTGATGGTGGGAAT-30 and 50-GGTGT
AAAACGCAGCTCAGT-30 and the a globin primers
were 50-CTGATTCTGACAGACTCAGG-30 and 50-AC
CAAGAGGTACAGGTGCAA-30. The a globin primers
did not distinguish between a1 and a2 because the
sequences are nearly identical. Multiplexed ampliﬁcation
of actin and a globin was performed at 1mM MgCl2 and
55 C annealing temperature and yielded 1020-bp (Actin)
and 525-bp (a1/2 globin) products. For quantitative PCR
(qPCR), validated TaqMan assays (Applied Biosystems)
were used with TaqMan gene expression master mix
(Applied Biosystems) on an ABI 7300 instrument under
default cycling conditions (95 C 15s followed by 60 C
1min for 45 cycles). Relative expression levels were
determined from a standard curve of serial dilutions of
wild-type cDNA samples and were normalized to Gapdh
expression levels. Control reactions lacking RT yielded
little or no signal.
ChIP assays
For each experiment, 2 10
6 fetal liver cells were
crosslinked in 0.4% or 1.0% formaldehyde and
sonicated with four 10-s pulses at 30% of maximum
power. IP dilution buﬀer (0.01% SDS, 1.1% Triton
X-100, 1.2mM EDTA, 16.7mM Tris at pH 8.1, 167mM
NaCl, protease inhibitors) was added, 5% of the volume
was removed and used as input while the remainder was
incubated overnight at 4 C with the appropriate antibody:
BRG1 (J1 antibody from G. Crabtree and W. Wang),
total H3 (Abcam), pan-acetyl H3 (H3ac, Millipore/
Upstate), H3K4me2 (Millipore/Upstate), GATA-1
(Santa Cruz), Pol II (Santa Cruz N-20) and P-Ser5 Pol
II (Covance). Protein A/G agarose beads (Santa Cruz)
were added and incubated for at least 2h at 4 C, and
then washed and eluted according to standard procedures.
qPCR was performed using Power SYBR Green Master
Mix (Applied Biosystems (Applied Biosystems) on an ABI
7300 instrument under default cycling conditions (95 C
15s followed by 60 C 1min for 45 C cycles). The MRE
primers were 50-CCTACACTAACTAGGTCAAAG30
and 50-TGCCCAGGTTTTGCTTCTCTT-30, while the
a2 promoter primers were 50-TGAGGCCAGAAGCAG
GTTGTG-30 and 50-GATCAAGGTCCTGTTCTCACC-
30. Dissociation curves and agarose gels demonstrated a
single PCR product in each case without primer dimers.
Relative enrichment was determined from a standard
curve of serial dilutions of input samples.
Co-IPs and western blots
Immunoprecipitations were performed as previously
described (27) with the following modiﬁcations. Single-
cell suspensions of E12.5 fetal liver cells were incubated
in the presence of 30mM dithiobissuccimdyl propionate
(DSP) (Pierce) at room temperature for 15min and
utilized anti-GATA-1 (Santa Cruz) or anti-EKLF
(AEK-1 provided by Yu-Chiau Shyu and Che-Kun
James Shen) (29). Western blots were performed with a
BRG1 antibody (Santa Cruz G-7) as described previously.
DNase I sensitivity assays
Real-time, quantitative DNase I sensitivity assays were
performed as previously described (30). The MRE and
6020 Nucleic Acids Research, 2009,Vol.37, No. 18a2 promoter primers and cycling conditions were the same
as for the ChIP assays (see above). The D9Mit59 control
primers were 50-CAGCCAGAGGCAGTGTTTTA-30 and
50-TAGGCTTCAGCTGCAACTCA-30.
Bisulﬁte mutagenesis
Bisulﬁte mutagenesis was performed as previously
described (27), and the MRE was ampliﬁed using 50-GTA
TATTTATATTAATTAGGTTAAAGTAG-30 and 50-AC
AAATCTACCCAAATTTTACTTCTCTTT-30 modiﬁed
primers. Subcloning and sequencing were also performed
as described previously. Over 95% of cytosines outside the
context of CpG were converted to thymines indicating
the sodium bisulﬁte mutagenesis step occurred eﬃciently.
3C assays
3C assays were performed as previously described (31).
Single-cell suspensions were isolated from wild-type and
Brg1 mutant E12.5 FLs. 3C products were normalized to
a control interaction at Ercc3. Band intensities were
quantiﬁed with ImageJ 1.38v software. 3C primer
sequences are available upon request.
RESULTS
BRG1 directly regulates a globin expression
We previously identiﬁed reduced transcription of the
a and b globin genes in ﬂow-sorted erythroid cells from
E12.5 Brg1
null/ENU1 fetal livers (FLs) (12,27,28). We
subsequently validated the b globin result and have
studied the role of BRG1 in b globin regulation
(12,27,28). To validate the a globin result, we performed
RT–PCR and demonstrated that expression is markedly
reduced in mutants (Figure 1B). RT–qPCR indicated that
mutants express a globin at 5-10% of wild-type levels
(Figure 1C). A similar reduction was observed for b
major previously and in this study (Figure 1C).
Transcription of the z and eY embryonic globin genes
from yolk sac derived primitive erythrocytes still
circulating at E12.5 was also reduced but to a lesser
extent,  60% of wild-type levels (Figure 1C), which is
similar to what was observed in Brg1
Tie2-Cre conditional
mutants (32). We have analyzed other genes whose
expression is not signiﬁcantly aﬀected in Brg1 mutants,
including Gata1, Fog1 and Eklf, which indicates BRG1
does not regulate the expression of erythroid transcription
factors and is not a general transcriptional co-regulator
(12,28). Here, we analyzed the mouse ortholog of
C16orf35 (also known as major alpha globin regulatory
element containing gene or Mare), which serves as an
important control because intron 5 contains the MRE.
C16orf35 mRNA levels are unaﬀected in mutants
(Figure 1C), which can be explained by the aforemen-
tioned 3C experiments demonstrating chromatin looping
at the a globin locus.
To determine whether BRG1 directly regulates the a
globin locus, we performed ChIP assays and localized it
to the MRE and a2 promoter in FLs (Figure 2A). BRG1
did not occupy either site in non-erythroid head tissue,
which indicates that it binds to the a globin locus in a
tissue-speciﬁc manner (Figure 2A). GATA-1 and EKLF
are also known to bind these sites and presumably recruit
BRG1 based on their ability to physically interact with
BRG1 in vitro and recruit it and SWI/SNF-related
complexes to the b globin locus (6,7,33–38). However,
these protein-protein interactions have not been
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Figure 1. BRG1 regulates a globin expression. (A) Schematic of the
mouse b globin (top) and a globin (bottom) loci on chromosomes 7
and 11, respectively. DNase I hypersensitive sites are depicted by
vertical arrowheads, while gray and black triangles represent
embryonic and fetal/adult globin genes, respectively. Each globin
gene has three exons, which are not shown, and the triangles point
to the right to indicate transcriptional orientation. The a globin locus
contains a gene (C16orf35) transcribed in the opposite orientation with
the ﬁrst seven exons shown as vertical bars. LCR, locus control region;
MRE, major regulatory element; HS, hypersensitive site. Coordinates
are shown in kb with the 0 position corresponding to the start of the
ﬁrst globin gene. (B) Expression of deﬁnitive a globin. Shown is an
image of an ethidium bromide stained agarose gel containing Actin and
a1/2 globin RT-PCR products ampliﬁed from wild-type (WT) and
mutant (Mut) E12.5 FLs. MW, 1-kb molecular-weight standard (the
2.1-, 1.6-, 1.0- and 0.5-kb bands are visible). (C) Quantitative real-time
RT–PCR analysis of a1/2, b major z, eY, and C16orf35 mRNA levels
normalized to Gapdh levels in wild-type (WT, unﬁlled) and mutant
(Mut, ﬁlled) E12.5 FLs. Each histogram shows the relative expression
of a particular gene (mean±SE for three independent experiments).
Nucleic Acids Research, 2009,Vol.37, No. 18 6021conﬁrmed at physiological levels in vivo. Therefore, we
performed co-immunoprecipitations (co-IPs) using E12.5
FLs, and western blot analyses indicated that endogenous
GATA-1 and EKLF physically interact with endogenous
BRG1 (Figure 2B). The ability of GATA-1 and EKLF to
bind BRG1 and recruit it to the a globin locus was
unaﬀected in mutants (Figure 2A, B). These ﬁndings are
consistent with the fact that the E1083G substitution is in
the ATPase domain located far away from the N-terminal
domain of BRG1 that binds these zinc-ﬁnger transcription
factors (7). BRG1 is also required for maximal GATA-1
occupancy at the MRE and a2 promoter (Figure 2C).
BRG1 confers DNase I sensitivity and mediates epigenetic
modiﬁcations of the MRE and a2 promoter
Considering that mutant BRG1 is recruited to the a globin
locus, we reasoned that impaired chromatin remodeling
underlies the reduced expression in mutants. DNase I
sensitivity assays demonstrated that the MRE and a2
promoter are hypersensitive in wild-type FL nuclei, as
expected, but are signiﬁcantly less sensitive in mutant
samples (Figure 3). An Mit microsattelite marker that is
relatively resistant to DNase I digestion served as a
control and is unaﬀected in mutant nuclei as expected
(Figure 3). To determine whether the reduced DNase I
sensitivity of mutant samples is correlated with higher
nucleosome density, we performed ChIP assays for total
histone 3 (H3) using an antibody that binds to the C
terminus. Compared to wild-type samples, mutants have
increased total H3 at the MRE and a2 promoter
(Figure 4A). Therefore, decreased DNase I sensitivity is
correlated with increased H3 in mutants, and these
ﬁndings are consistent with the role of BRG1 directly
altering the conformation and position of nucleosomes.
To assess chromatin structure in more detail, we
evaluated two covalent histone modiﬁcations associated
with transcriptionally permissive promoters. In wild-type
FLs, the MRE and a2 promoter are enriched for H3
acetylation (H3ac) and H3 lysine 4 dimethylation
(H3K4me2) in erythroid cells of the FL several fold
higher than non-erythroid cells of the head as expected
(Figure 4B, C). In contrast, mutant FLs had low-level
enrichment of H3ac comparable to head tissue at both
sites (Figure 4B). Higher H3ac levels in wild-type
compared to mutant is consistent with BRG1 having a
bromodomain and functioning in concert with HATs.
Mutant FLs also had lower levels of H3K4me2 similar
in magnitude to H3ac (Figure 4C). The previous total
H3 ChIP experiment (Figure 4A) serves as a control to
indicate that decreased H3ac and H3K4me2 in mutants is
not due to depletion of H3. The eﬀect of BRG1 on H3ac
and H3K4me is presumably indirect and could be a con-
sequence of decreased transcription (39).
Sodium bisulﬁte mutagenesis assays were also
performed to evaluate DNA methylation. Wild-type and
mutant samples were hypomethylated to a similar degree
(Supplementary Figure 1). These results are diﬀerent
than what we previously observed at the b globin locus
where wild-type samples were hypomethylated to an even
greater extent and mutants were hypermethylated (27).
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Figure 2. BRG1 occupies the a globin locus and physically interacts
with GATA-1 and EKLF in vivo.( A) Quantitative ChIP assays
demonstrating that wild-type (WT) and mutant (Mut) BRG1 are
localized to the MRE and a2 promoter. FL or head (H) samples
were immunoprecipitated with BRG1 antibody (+) or pre-immune
serum ( ), which were otherwise processed identically and serve as
negative controls. Histograms show the relative enrichment by
comparing each ChIP sample to input by qPCR (mean±SE for
three independent experiments). (B) GATA-1 and EKLF co-IP with
BRG1 in vivo. Shown are western blot panels probed with a BRG1
antibody (aBRG1). Samples include wild-type (WT) and mutant (Mut)
E12.5 FLs (Input) and protein lysates immunoprecipitated with
aGATA-1 (left)o raEKLF (right) from FLs. Mock, WT FLs
immunoprecipitated in the absence of aGATA-1 or aEKLF but
processed in an identical manner. (C) Quantitative ChIP assays of
GATA-1 occupancy at the MRE and a2 promoter in wild-type (WT)
and Brg1 mutants (Mut). FL samples were immunoprecipated with
GATA-1 antibody (+) or pre-immune serum ( ), which were
otherwise processed identically and serve as negative controls.
Histograms show the relative enrichment by comparing each ChIP
sample to input by qPCR (mean±SE for three independent
experiments).
6022 Nucleic Acids Research, 2009,Vol.37, No. 18Previous studies have demonstrated that hypomethylation
at the a globin locus occurs in erythroid and non-
expressing tissues, whereas hypomethylation at the b
globin locus occurs only in erythroid tissues (40–42).
Therefore, CpG methylation appears to be less utilized
as a regulatory mechanism at the a globin locus
compared to the b globin locus.
BRG1 induces chromatin looping between the MRE and a2
promotor and facilitates maximal RNA Polymerase II
occupancy at the a2 promotor
BRG1 has been shown to mediate chromatin looping
between far-upstream regulatory elements and promoters
at the CIITA and b globin loci (12,43). The MRE and a2
promoter are also known to undergo chromatin looping
(24–26), so we hypothesized that BRG1 is required for this
process to occur considering that it regulates nucleosome
structure/position (manifest by reduced DNase I sensitiv-
ity and increased H3 in mutants) and covalent histone
modiﬁcations at both sites. Therefore, we performed
semi-quantitative 3C experiments and determined that
the MRE and a2 promoter are in close physical
proximity in wild-type FLs (Figure 5A), which is in
accord with previously published studies. Importantly,
however, this MRE-a2 promoter chromatin loop is
undetectable in mutant samples (Figure 5A), despite
having restriction enzyme cleavage eﬃciencies similar to
wild-type samples (Figure 5B). BRG1 does not participate
in chromatin-loop formation at several other loci
including c-Kit and Gata2, which indicates that it does
not play a general, non-speciﬁc role in chromatin-loop
formation throughout the genome (12,43).
Chromatin looping is thought to transfer RNA
Polymerase II (Pol II) from upstream regulatory
elements to the promoter to facilitate transcription
(44). Consistent with this notion, the Brg1 mutation
does not aﬀect Pol II occupancy at the MRE but the
loss of chromatin looping in Brg1 mutants is associated
with loss of high-level occupancy of Pol II and P-Ser5
Pol II at the a2 promoter (Figure 5C, D). This ﬁnding
is similar to Drosophila BRM promoting Pol II associa-
tion with polytene chromosomes (39) and accounts
for the observed decrease in a globin transcription in
this study.
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Figure 4. Aberrant epigenetic modiﬁcations at the a globin locus in
Brg1 mutants. (A–C) Quantitative ChIP assays showing total H3 (A),
H3ac (B) and H3K4me2 (C) at the MRE and a2 promoter from
wild-type (WT, unﬁlled) and mutant (Mut, ﬁlled) fetal liver (FL) and
head (H) samples. FL samples were also immunoprecipitated with pre-
immune (PI) serum, which were otherwise processed identically to
ChIPs and serve as negative controls. Histograms show the relative
enrichment by comparing each ChIP sample to input by qPCR
(mean±SE for three independent experiments).
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Figure 3. DNase I sensitivity of the a globin locus is reduced in Brg1 mutants. Nuclei from wild-type (WT) and mutant (Mut) E12.5 FL cells were
undigested (0.0) or digested with increasing amounts of DNase I (from left to right: 0.1, 0.50, 1.0U). Genomic DNA was subsequently prepared, and
the percentage of templates remaining for the MRE and a2 promoter was determined by comparing qPCR yields to a standard curve of DNA from
undigested sample qPCR yields (mean±SE for three independent experiments). To correct for small diﬀerences in the amount of DNA that might
have been recovered from each sample, an Mit marker that is relatively resistant to DNase I was ampliﬁed as a control; *P<0.01; **P<0.001.
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Moleculardeterminantsofhistoneacetylation,nucleosome
remodeling and chromatin looping at the a globin locus
are unknown. Here, we demonstrate that the BRG1
catalytic subunit of SWI/SNF-related complexes is
required for each of these inter-related processes and for
a globin transcription. We also demonstrate that
chromatin looping between the MRE2 and a2 promoter
is an essential part of the mechanism of the transcriptional
activation mechanism. In this regard, it is noteworthy that
not all chromatin loops will be functionally important.
For example, the H enhancer undergoes chromatin
looping with numerous olfactory receptor genes but is
required for the expression of only a relatively small
subset that are most tightly linked (45).
Other transcription factors and chromatin-modifying
factors are likely involved in chromatin-loop formation
between the MRE and a2 promoter, and GATA-1 and
FOG-1 are good candidates because they recruit BRG1
and are required for chromatin looping at the b globin
locus (24,46). It should be noted, however, that EKLF
also recruits BRG1 and is essential for chromatin
looping at the b globin locus but is dispensable for
chromatin looping at the a globin locus (24). CTCF is
also required for chromatin looping at the b globin
locus but is not a good candidate because it is not
known to bind the a globin locus or regulate its expres-
sion (47). Conversely, ATRX is a good candidate because
it is a putative chromatin-remodeling factor similar to
BRG1 and is required for a globin expression (48,49).
Based on our previous work and data presented here,
we propose that BRG1 performs a similar role at the a
and b globin loci: 1, it binds to GATA-1, EKLF, and
possibly other transcription factors such as p45/NF-E2
in erythroblasts (50), which leads to the recruitment of
SWI/SNF-related complexes to the far-upstream regula-
tory elements (the aMRE and bLCR) and globin
promoters; 2, it confers DNA-dependent ATPase
activity and harnesses this energy to alter nucleosome con-
formation and position directly and promotes histone
acetylation and H3K4me2 indirectly; 3, it is required for
chromatin looping between the MRE-a2 promoter and
the LCR-b major promoter, which is thought to transfer
Pol II from the upstream regulatory elements to the
promoters and initiate transcription (44).
LCR mutants phenocopy Brg1 mutants, which
supports our model, but MRE mutants have a smaller
decrease in a globin transcription (reduced to 50% of
normal) and exhibit a more subtle phenotype (51,52).
To reconcile this diﬀerence, the LCR consists of six HSs
that function in an additive manner such that deletion of
any one HS results in a relatively mild phenotype.
Similarly, deletion of the MRE plus the other four HSs
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Figure 5. BRG1 is required for chromatin looping and maximal Pol II promoter occupancy at the a globin promoter. (A) 3C strategy. HindIII
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E12.5 FL cells from wild-type (WT) and Brg1 mutant (Mut) embryos (mean±SE, two independent experiments). (B) Real-time PCR quantiﬁcation
of HindIII cleavage eﬃciencies for the WT and Mut samples. (C and D) Quantitative ChIP assays showing Pol II (C), and P-Ser5 Pol II (D) at the
MRE and a2 promoter from wild-type (WT, unﬁlled) and mutant (Mut, ﬁlled) FL samples. Samples were immunoprecipitated with Pol II or P-Ser5
Pol II antibody (+) or pre-immune serum ( ), which were otherwise processed identically and serve as negative controls. Histograms show the
relative enrichment of Pol II occupancy by comparing each ChIP sample to input by qPCR (mean±SE for three independent experiments);
*P<0.003.
6024 Nucleic Acids Research, 2009,Vol.37, No. 18at the mouse a globin locus, even though they confer less
enhancer activity than the MRE when incorporated into
transgenes, may result in a more severe phenotype similar
to Brg1 mutants. There are also human–mouse diﬀerences
with the human MRE playing a more important role
based on transgenic mouse experiments and deletions in
thalassemia patients (19,22). A gene-targeting experiment
also has been performed that replaced 85kb of the mouse
a globin locus with the corresponding 120kb of human
sequence; although the human a globin genes knocked
into the mouse were expressed in a tissue- and stage-
appropriate manner, mRNA levels were 60% less than
endogenous mouse transcripts (53). The MRE might
function diﬀerently between the two species, despite
being highly conserved, because of breaks in the
conserved synteny within the locus that occurred after
the rodent and primate lineages diverged (54).
The a and b globin loci are known to move from their
chromosomal territories at the nuclear periphery, where
they are transcribed at low levels, to transcription
factories where multiple chromatin loops converge at Pol
II foci and transcription is upregulated (25,55,56). The
LCR is required for re-localization of b globin from its
repressive compartment to transcription factories (56), but
no other cis elements or trans-acting factors have been
identiﬁed that are required for this process to occur at
b globin or any other locus to our knowledge. BRG1 is
an attractive candidate because it is a DNA-dependent
ATPase that could provide the necessary energy and it
participates in the formation of local chromatin loops,
referred to as active chromatin hubs, at the a and b
globin loci. Additionally, SWI/SNF-related complexes
contain actin and actin-related subunits that could poten-
tially move loci via the nuclear cytoskeleton/matrix
to transcription factories (57). It must be determined
whether BRG1 functions exclusively in the formation of
local chromatin loops (where active chromatin hubs allow
upstream enhancers to load Pol II onto promoters) or if it
also transports these domains to transcription factories.
In summary, BRG1 plays a fundamental role in
the mechanism of transcriptional activation at the a
globin locus as well as the b globin locus. Our ﬁndings
reveal a common regulatory mechanism, notwithstanding
certain diﬀerences such as the role of EKLF and CpG
methylation, which was not anticipated because the a
globin locus contains a ubiquitously expressed gene
(C16orf35) and lacks a CTCF insulator.
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